Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Global Health Impact Network & Funds is a clinician-driven venture capital and expert network investing in early-stage healthcare startups. They focus on innovations in digital health, telemedicine, precision medicine, maternal health technologies (such as fetal monitoring), and AI-enabled medical solutions. Their portfolio includes companies like Raydiant Oximetry (fetal monitoring), Elucid (AI for cardiovascular care), Somnoware (sleep/respiratory diagnostics; exited), Uberdoc (telemedicine access), Elemeno Health (nurse support tools), Plethy (musculoskeletal care), Vitel Health (cloud-based patient-doctor connection software), and Handzin (healthcare collaboration platform).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Global Health Impact Network & Funds.